Post-doc position in viro-immunology

We are inviting application from enthusiastic post-doctoral candidate to participate in our project supported by the French National Agency (ANR), 2-year position – possible extension. The research program centers on the innate immune response
against viral infection.
Type I interferons are first line of host defense to protect against viral infections. The most robust producer cell type is the plasmacytoid dendritic cell (pDC). We aim at defining how IFN-I response control viral infection.
Dengue virus serve as primary viral model for our project, yet our main findings are studied to other viruses to define the broad
versus virus-specific regulation. More recently, we have initiated research on SARS-CoV2.


Originality: answer question on the host/pathogen interactions using approaches from disparate fields, cellular biology, immunology and virology.
Well-positioned to carry out studies from molecular to organism levels.
Part of CIRI: a center for infectious disease research, promoting an integrated approach
State-of-the-art facilities for imaging, FACS, etc..
Biosafety Level 3 laboratories and animal housing.
ENS, Campus Charles Mérieux ( endowed with strong basic biology sciences.


Strong background in cell biology and immunology.
Prior experiences in in vivo mouse studies and/or imaging/microscopy techniques is highly advantageous.
Self-motivation, flexibility, curious and enthusiastic to work in a collaborative team.
Proven ability to identify key research objectives
Written and communication skills in English

Team lead by Dr M. Dreux at the CIRI
Please send one PDF file to Marlene Dreux containing the following:
– cover letter
(with short statement of the research interests)
– concise summary of previous research training
– curriculum vitae including publication list and contact details for 3 referees.

Position available as soon as October 2020


Articles Récents

Prix de thèse 2022
janvier 25, 2023
janvier 25, 2023
Offre de CDD Assistant Ingénieur. Equipe « Oncogenèse Rétrovirale » au CIRI, Lyon.
janvier 23, 2023